Moderna, Inc.
NasdaqGS:MRNA
$ 125.00
$-0.59 (-0.47%)
$ 125.00
$-0.59 (-0.47%)
End-of-day quote: 05/03/2024

Moderna financials at a glance

The revenue of Moderna is reported as 6.848 billion Dollars in the fiscal year 2023. The earnings were -12.33 Dollars per share in 2023, which was 161.28 lower than 2022. And about -3.825 billion Dollars are reported as free cash flow in the financials of Moderna 2023. No dividends were paid to the shareholders of the Moderna stock NasdaqGS:MRNA in the financial year 2023.

$6.85B
Revenue
$-12.33
Earnings Per Share
-39.28%
Gross Margin %
$-4,611.05M
Free Cash Flow
Revenue
6,848.00
Earnings Per Share
-12.33
Gross Margin %
-39.28
Free Cash Flow
-4,611.05

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018
Rev. Revenue N/A $6.85B $19.26B $18.47B $803.40M $60.21M $135.07M
GM % Gross Margin % -13.28% -39.28% 54.78% 75.05% -71.61% 0.00% -,236.19%
OM Operating Margin -29.22% -61.90% 48.90% 71.98% -95.02% 0.00% 0.00%
EPS Earnings Per Share $-9.04 $-12.33 $20.12 $28.29 $-1.96 $-1.55 $-1.22
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 -0.00% 0.00% 0.00% -0.00% -0.00% -0.00%
Sha. Shares N/AM 382.07M 386.34M 402.87M 399.77M 368.64M 329M
OCF Operating Cash Flow N/A $-3,118.00M $4.98B $13.62B $2.03B $-,458.97M $-,330.87M
FCF Free Cash Flow N/A $-4,611.05M $4.58B $13.34B $1.96B $-,490.52M $-,436.63M
FCFS Free Cash Flow Per Share $-6.93 $-10.01 $11.63 $33.09 $5.14 $-1.48 $-5.38